Back
Speaker illustration

Doctor Siddharth Patel

Brigham and Women's Hospital, Boston (United States of America)

Member of:

European Society of Cardiology

Presentations

Renal function and factor XI inhibition in atrial fibrillation: a pre-specified analysis of AZALEA-TIMI 71

Event: ESC Congress 2025

Topic: Stroke Prevention

Session: Oral anticoagulation in atrial fibrillation: new insights

Access
Like
Thumbnail

Prior anticoagulation experience, bleeding risk, and safety of factor XI inhibition in atrial fibrillation: an analysis of AZALEA-TIMI 71

Event: ESC Congress 2025

Topic: Stroke Prevention

Session: Oral anticoagulation in atrial fibrillation: new insights

Access
Like
Thumbnail

Long-acting Factor XI Inhibition and Periprocedural Bleeding: A Secondary Analysis from AZALEA-TIMI 71

Event: ESC Congress 2024

Topic: Stroke Prevention

Session: Smaller trials, trial updates, and other studies on antiplatelet and antithrombotic therapies

Access
Like
Thumbnail

Characteristics and prognostic implications of pre-shock and normotensive cardiogenic shock in the Critical Care Cardiology Trials Network Registry

Event: ESC Congress 2023

Topic: Cardiogenic Shock

Session: Prognostication and mechanical support in cardiogenic shock

Access
Like
Thumbnail

Risk and benefits of baseline antiplatelet therapy in 58,598 patients with atrial fibrillation randomized to NOACs vs warfarin

Event: ESC Congress 2023

Topic: Anticoagulants

Session: Oral anticoagulation in patients with atrial fibrillation

Access
Like
Thumbnail

Lipoprotein(a), cardiovascular events, and benefit of P2Y12 inhibition: insights from the PEGASUS-TIMI 54 trial

Event: ESC Congress 2022

Topic: Pharmacotherapy

Session: Coronary artery disease - Pharmacotherapy 3

Access
Like
Thumbnail

ESC 365 is supported by

bristol-myers-squibb Explore sponsored resources
novartis Explore sponsored resources
novo-nordisk Explore sponsored resources